Antiretroviral drug used to prevent HIV or hepatitis B shows promise for Alzheimer’s disease treatment in early clinical trials

  Contact: Eileen Teves, 210-450-7239, tevese@uthscsa.edu Content provided by Claire Kowalick SAN ANTONIO – A pilot study led by scientists from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) shows promise for people with mild cognitive changes treated with lamivudine, a Food and Drug Administration-approved antiretroviral drug. The study reveals […]